Suppr超能文献

感染在镰状细胞病患者血管阻塞性危象发病机制中的作用。

The role of infection in the pathogenesis of vaso-occlusive crisis in patients with sickle cell disease.

机构信息

Department of Haematology, Aminu Kano Teaching Hospital.

出版信息

Mediterr J Hematol Infect Dis. 2011;3(1):e2011028. doi: 10.4084/MJHID.2011.028. Epub 2011 Jul 8.

Abstract

Sickle cell disease (SCD) is characterized by recurrent vaso-occlusive crisis (VOC). Patients with SCD have impaired immunity and are thus predispose to infections. The vast majority of SCD patients live in underdeveloped nations with high prevalence and transmission rates of infections. This makes the SCD patients prone to infections, which frequently precipitate VOC. We reviewed the role of infection in the pathogenesis of VOC, taking into consideration all potential mechanisms from previous studies and hypothetical perspectives. The potential mechanisms through which infections may lead to VOC involve several pathological changes including pneumonitis, pyrexia, acute phase reaction, hypercoagulability, neutrophilia, eosinophilia, thrombocytosis, bronchospasm, red cell cytopathic and membrane changes, auto-antibodies mediated red cell agglutination and opsonization, diarrhoea and vomiting, which may act singly or in concert to cause red cell sickling. These changes can induce sickling directly or indirectly through their adverse effects on Hb oxygenation and polymerization, hydration, blood viscosity, red cell metabolism, procoagulant activation, intercellular adherence and aggregation, culminating in VOC. There is therefore the need to ameliorate the burden of infection on SCD through immunization, prophylactic and therapeutic use of antimicrobials, barrier protection and vector control in communities with high prevalence of SCD.

摘要

镰状细胞病(SCD)的特征是反复发作的血管阻塞性危象(VOC)。SCD 患者的免疫功能受损,因此易感染。绝大多数 SCD 患者生活在感染率和传播率较高的欠发达国家。这使得 SCD 患者容易感染,而感染常常会引发 VOC。我们回顾了感染在 VOC 发病机制中的作用,考虑了来自先前研究和假设视角的所有潜在机制。感染可能导致 VOC 的潜在机制包括几种病理变化,包括肺炎、发热、急性期反应、高凝状态、中性粒细胞增多、嗜酸性粒细胞增多、血小板增多、支气管痉挛、红细胞细胞病变和膜变化、自身抗体介导的红细胞聚集和调理作用、腹泻和呕吐,这些变化可能单独或协同作用导致红细胞镰变。这些变化可以通过对 Hb 氧合和聚合、水合作用、血液粘度、红细胞代谢、促凝激活、细胞间黏附和聚集的不利影响直接或间接诱导镰变,最终导致 VOC。因此,有必要通过免疫接种、预防性和治疗性使用抗生素、社区中的屏障保护和病媒控制来减轻 SCD 患者的感染负担。

相似文献

1
The role of infection in the pathogenesis of vaso-occlusive crisis in patients with sickle cell disease.
Mediterr J Hematol Infect Dis. 2011;3(1):e2011028. doi: 10.4084/MJHID.2011.028. Epub 2011 Jul 8.
2
Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
J Thromb Haemost. 2017 Jul;15(7):1392-1402. doi: 10.1111/jth.13728. Epub 2017 Jun 5.
3
Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.
Clin Vaccine Immunol. 2010 Apr;17(4):602-8. doi: 10.1128/CVI.00145-09. Epub 2010 Feb 3.
5
Conjunctival microvascular hemodynamics following vaso-occlusive crisis in sickle cell disease.
Clin Hemorheol Microcirc. 2015 Sep 25;62(4):359-67. doi: 10.3233/CH-151977.
6
Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20.
7
Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
Hematology. 2014 Jan;19(1):52-9. doi: 10.1179/1607845413Y.0000000092. Epub 2013 Nov 25.
8
Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
Eur J Haematol. 2022 Sep;109(3):226-237. doi: 10.1111/ejh.13790. Epub 2022 Jun 20.
9
Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD.
Blood. 2019 Aug 15;134(7):579-590. doi: 10.1182/blood.2019000172. Epub 2019 May 10.

引用本文的文献

3
Impaired phagocytosis and oxidative respiratory burst activity in sickle cell anemia leukocytes.
J Taibah Univ Med Sci. 2024 Aug 10;19(4):867-876. doi: 10.1016/j.jtumed.2024.07.010. eCollection 2024 Aug.
4
The Association between Adenotonsillectomy and Frequency of Vaso-Occlusive Crises in Patients with Sickle Cell Disease.
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):5499-5505. doi: 10.1007/s12070-021-02696-5. Epub 2021 Aug 22.
5
Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease.
Blood. 2022 Jun 30;139(26):3771-3777. doi: 10.1182/blood.2021014473.
6
Strategies to increase access to basic sickle cell disease care in low- and middle-income countries.
Expert Rev Hematol. 2022 Apr;15(4):333-344. doi: 10.1080/17474086.2022.2063116. Epub 2022 Apr 12.
7
Sickle cell disease and COVID-19 in pregnant women.
J Gynecol Obstet Hum Reprod. 2022 Mar;51(3):102328. doi: 10.1016/j.jogoh.2022.102328. Epub 2022 Jan 29.
9
Concurrent Bilateral Central Retinal Artery Occlusion Secondary to Sickle Cell Crisis.
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211028392. doi: 10.1177/23247096211028392.

本文引用的文献

1
Hematological indices of sickle cell anaemia patients with pulmonary tuberculosis in northern Nigeria.
Mediterr J Hematol Infect Dis. 2010 Jun 7;2(1):e2010014. doi: 10.4084/MJHID.2010.014.
3
Management of painful vaso-occlusive crisis of sickle-cell anemia: consensus opinion.
Clin Appl Thromb Hemost. 2010 Aug;16(4):365-76. doi: 10.1177/1076029609352661. Epub 2010 Jun 7.
5
Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy.
Transfusion. 2010 May;50(5):1144-55. doi: 10.1111/j.1537-2995.2009.02551.x. Epub 2010 Jan 15.
6
Inflammation and coagulation.
Crit Care Med. 2010 Feb;38(2 Suppl):S26-34. doi: 10.1097/CCM.0b013e3181c98d21.
8
Pulmonary complications of sickle cell disease.
N Engl J Med. 2008 Nov 20;359(21):2254-65. doi: 10.1056/NEJMra0804411.
9
10
Managing acute chest syndrome of sickle cell disease in an African setting.
Trans R Soc Trop Med Hyg. 2008 Jun;102(6):526-31. doi: 10.1016/j.trstmh.2008.03.018. Epub 2008 May 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验